Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Abdominal Cancer × Influenza Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Influenza, Human 9 Neoplasms 5 Colorectal Neoplasms 2 Central Nervous System Neoplasms 2 Waldenstrom Macroglobulinemia 1 Virus Diseases 1 Vaccine-Preventable Diseases 1 Vaccination Hesitancy 1 Patient Acceptance of Health Care 1 Oligodendroglioma 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Infections 1 Health Behavior 1 Glioma 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms 1 Astrocytoma 1 Abdominal Cancer 1

Interventions

Tea 2 Bupivacaine 2 Tadalafil 1 Supine Position 1 Morphine 1 Ketamine 1 Injections, Subcutaneous 1 Influenza Vaccines 1 Head-Down Tilt 1 Dexmedetomidine 1 Anesthetics, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02998736 2022-12-28

PERIOP-04

Ottawa Hospital Research Institute

Phase 1 Completed

Abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡